Xiaomao Yin

发表

An in situ molecular signature to predict early recurrence in hepatitis B virus-related hepatocellular carcinoma.

J. Yun, W. Jia, J. Xu, 2012, Journal of hepatology.

Simvastatin enhances the chemotherapeutic efficacy of S-1 against bile duct cancer: E2F-1/TS downregulation might be the mechanism

L. Liang, Jianpeng Cai, Wei Chen, 2013, Anti-cancer drugs.

Elevation of miR-27 b by HPV 16 E 7 inhibits PPARγ expression and promotes proliferation and invasion in cervical carcinoma cells

Fei Liu, Lei Zheng, Jin-lan Huang, 2015 .

Tumor-Activated Monocytes Promote Expansion of IL-17–Producing CD8+ T Cells in Hepatocellular Carcinoma Patients

D. Kuang, Ling Zhu, Lian Li, 2010, The Journal of Immunology.

Development of a novel gene signature to predict prognosis and response to PD-1 blockade in clear cell renal cell carcinoma

W. Kong, Zaoyu Wang, Jin Zhang, 2021, Oncoimmunology.

Identification of biomarkers of chromophobe renal cell carcinoma by weighted gene co-expression network analysis

Jin Zhang, Jianfeng Wang, Xiaomao Yin, 2018, Cancer Cell International.

SUV39H1 deficiency suppresses clear cell renal cell carcinoma growth by inducing ferroptosis

W. Xue, Jin Zhang, Yiran Huang, 2020, Acta pharmaceutica Sinica. B.

PRMT1 is a novel molecular therapeutic target for clear cell renal cell carcinoma

Kaixian Chen, Hao Jiang, C. Luo, 2021, Theranostics.

Identification of biomarkers of chromophobe renal cell carcinoma by weighted gene co-expression network analysis

Jin Zhang, Jianfeng Wang, X. Yin, 2018, Cancer Cell International.

EYA4 inhibits hepatocellular carcinoma growth and invasion by suppressing NF-κB-dependent RAP1 transactivation

Dong Chen, Shijing Mo, Jianpeng Cai, 2018, Cancer communications.